A. Ullrich - Concepedia

Author

A. Ullrich

Max Planck Institute of Biochemistry

Also Known As

A ULLRICH, A Ullrich, A. Ullrich, A. Ullrich*, Axel Ullrich, Personalia, Peter O. Hackel

215

Publications

38.6K

Citations

H-Index

164

Concepts

All Affiliations

Max Planck Institute of Biochemistry Max Planck Society Columbia University Irving Medical Center New York University

About

A. Ullrich is an author at Max Planck Institute of Biochemistry specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	78	136	26.1K
2	Natural Sciences	31	38	4.9K
3	Health Sciences	10	10	1.2K
4	Engineering	4	4	780
5	Public Health	1	1	54

A. Ullrich

171

Publications

31.6K

Citations

H-Index

Page 1

	Year	Citations
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences Julian Downward, Yosef Yarden, E. L. V. Mayes, Nature Developmental BiologySignal TransductionSignaling PathwayReceptor Tyrosine KinaseClose Similarity	1984	2.5K
Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. A. Ullrich, Andrew Gray, Albert W. Tam, The EMBO Journal Molecular PhysiologySignal TransductionDevelopmental BiologyInsulin-like Growth FactorG Protein-coupled Receptor	1986	1.9K
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling Eve J. Lowenstein, Roger J. Daly, Andreas Batzer, Cell	1992	1.6K
Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. Yosef Yarden, Wun-Jing Kuang, Teresa L. Yang‐Feng, The EMBO Journal Signal TransductionHuman Proto-oncogene C-kitCell RegulationOncogenic AgentCell Signaling	1987	1.6K
Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors Yosef Yarden, J A Escobedo, Wun-Jing Kuang, Nature ThrombopoiesisSignal TransductionDevelopmental BiologyBlood PlateletGrowth Hormone	1986	1.2K
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. T. Annie T. Fong, Laura K. Shawver, Li Sun, PubMed Novel Synthetic CompoundChemoprevention StrategyPathologyTyrosine Kinase CatalysisTumor Biology	1999	1K
EGF induces tyrosine phosphorylation of phospholipase C-II: A potential mechanism for EGF receptor signaling Ben Margolis, Sue Goo Rhee, Stephen Felder, Cell Signal TransductionDevelopmental BiologySignaling PathwayReceptor Tyrosine KinaseReceptor (Biochemistry)	1989	777
The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. E. Y. Skolnik, Chi‐Hon Lee, Andreas Batzer, The EMBO Journal Insulin ControlInsulin SignalingMolecular PhysiologySignal TransductionSignaling Pathway	1993	706
Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases Edward Y. Skolnik, Ben Margolis, Moosa Mohammadi, Cell	1991	643
Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. Axel Knebel, Hans J. Rahmsdorf, A. Ullrich, The EMBO Journal Receptor TyrosineRadiation MedicineSignal TransductionEngineeringRadiation Biology	1996	515

Page 1